Analysis 3.11. Comparison 3 Budesonide/formoterol (BDF) versus placebo (PLA), Outcome 11 Withdrawals due to worsening COPD symptoms.
Review: Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Comparison: 3 Budesonide/formoterol (BDF) versus placebo (PLA)
Outcome: 11 Withdrawals due to worsening COPD symptoms
![]() |